复发性左心室辅助装置特异性感染新治疗策略的初步结果
本研究纳入9例复发性心室辅助装置驱动线或泵袋感染患者,采用冷大气等离子体联合特殊敷料技术、负压伤口治疗及碳布垫层和次氯酸盐冲洗液的新组合策略。中位治疗3周后全部患者即刻应答,6例完全愈合,5例达到主要终点且中位随访17.5个月无复发,3例感染控制后出院,无副作用。
要点
- 新组合策略在中位3周治疗下全部患者即刻应答,6例完全愈合。
- 5例达到主要终点,中位随访17.5个月感染未复发。
- 3例感染控制后出院,其中1例目的地治疗患者死亡,2例因铜绿假单胞菌感染复发紧急心脏移植。
核心结论
- 新组合治疗为心室辅助装置复发性感染患者提供了有前景的选择,但需进一步研究证实这些初步结果。
研究设计与样本
- 2016年1月至2018年1月,9例复发性感染的驱动线或泵袋感染患者接受新组合策略治疗。
- 主要终点为治疗后第一年内同一部位无感染复发的完全伤口愈合。
- 次要终点为感染控制,即感染区域显著缩小。
主要发现
- 中位治疗3周后全部患者即刻应答,6例完全愈合。
- 5例达到主要终点,中位随访17.5个月(范围12.1至21.8个月)感染未复发。
- 1例伤口治疗成功(完全愈合)后6个月接受心脏移植。
- 剩余3例感染控制后出院,中位随访5.7个月后1例目的地治疗患者在家中死亡,2例因铜绿假单胞菌感染复发紧急心脏移植。
- 未观察到副作用。
临床怎么用
- 对于复发性心室辅助装置特异性感染,可考虑冷大气等离子体联合特殊敷料、负压伤口治疗及碳布垫层和次氯酸盐冲洗的综合策略。
局限性
- 本研究为初步结果,样本量小,需进一步研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Relapsed ventricular assist device-specific infections are associated with high morbidity, mortality, and hospital costs. A new combination of cold atmospheric plasma and special dressing technique with negative pressure wound therapy with an additional underlay of carbon cloth and hypochlorite rinsing solutions has been developed and reported in this study. METHODS: Between January 2016 and January 2018, 9 patients with relapsed infected driveline or pump pocket infection were treated with this new combined strategy. The primary endpoint was complete wound healing without recurrence of infection, defined as the presence at the same site within the first year after treatment. The secondary endpoint was control of infection, defined as a marked reduction of the infected area. RESULTS: After a median treatment time of 3 weeks, an immediate response was observed in all patients, and complete healing was achieved in 6 patients. Five patients met the primary endpoint, and infection did not recur after a median follow-up of 17.5 (range, 12.1 to 21.8) months. One patient underwent heart transplantation 6 months after successful wound treatment (complete wound healing). The remaining 3 patients were discharged with controlled infection. After a median follow-up of 5.7 months, 1 destination therapy patient died at home, and 2 patients underwent urgent heart transplantation because of recurrence of infection caused by Pseudomonas aeruginosa. Side effects were not observed. CONCLUSIONS: The new combination treatment offers a promising option for patients with ventricular assist device-relapsed infection. Despite this, further studies are warranted to confirm those encouraging preliminary results.
引用
- Rotering H, Al Shakaki M, Welp H, et al. Preliminary Results of a New Treatment Strategy for Relapsed Left Ventricular Assist Device-Specific Infections. Ann Thorac Surg. 2020. PMID: 32169499. doi:10.1016/j.athoracsur.2020.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。